Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentContemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative reviewPrepulse inhibition in HIV-associated neurocognitive disorders.Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium.Executive Dyscontrol of Learning and Memory: Findings from a Clade C HIV-positive South African Sample.Objective impairments of gait and balance in adults living with HIV-1 infection: a systematic review and meta-analysis of observational studies.Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice.White matter fiber bundle lengths are shorter in cART naive HIV: an analysis of quantitative diffusion tractography in South Africa.HIV-Associated Neurocognitive Disorders: A Global Perspective.A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults.Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment.
P2860
Q26766448-7722C252-1D1E-4940-9165-EFB0EE5BFAABQ26783160-EBBE4776-BFA1-4B6C-B3BA-76BF1B72CDE6Q30451688-C5FA2DD3-3FFE-4452-9255-10C35E6192FEQ33890060-94C41E7F-A5FB-414D-9EEA-19F9AA6E3840Q34714684-3BE912A9-9A93-4FC5-BB1A-DE1B1DCBD3A3Q35883236-F72D417E-C062-4CFB-83CE-B8EFC9DBCE68Q37433079-D6961622-A26A-4D8C-BC4C-A633B66E7C7BQ38400463-CD26F2BC-FD90-4466-8860-80A009348289Q38648493-A8393051-27C0-4506-B9DA-29E9733A5054Q38658460-C7AF096F-A558-4959-AEA7-868F8964598DQ42266304-5A7A828B-50F3-4AA6-8DC8-60D04460DA16Q45994771-C5800E9F-7C57-4554-B407-ADBB7BA0EAD4Q46077781-5996D54B-4969-4770-A553-89EE9893EB54Q47203749-EEC7E4B8-1964-4381-89A2-C1F6F681F92AQ47547047-3A7B1E87-9B45-4727-9193-AD99CFB7DD97
P2860
Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neuropsychological outcomes in ...... h Africa: a prospective study.
@ast
Neuropsychological outcomes in ...... h Africa: a prospective study.
@en
Neuropsychological outcomes in ...... h Africa: a prospective study.
@nl
type
label
Neuropsychological outcomes in ...... h Africa: a prospective study.
@ast
Neuropsychological outcomes in ...... h Africa: a prospective study.
@en
Neuropsychological outcomes in ...... h Africa: a prospective study.
@nl
prefLabel
Neuropsychological outcomes in ...... h Africa: a prospective study.
@ast
Neuropsychological outcomes in ...... h Africa: a prospective study.
@en
Neuropsychological outcomes in ...... h Africa: a prospective study.
@nl
P2093
P2860
P356
P1476
Neuropsychological outcomes in ...... h Africa: a prospective study.
@en
P2093
Jacqueline Hoare
Jennifer Westgarth-Taylor
John A Joska
Kevin G F Thomas
Robert Paul
P2860
P2888
P356
10.1186/1471-2334-12-39
P577
2012-02-15T00:00:00Z
P5875
P6179
1027722632